ReviewClinical pharmacology and therapeutics2017

Targeting BCL2 With BH3 Mimetics: Basic Science and Clinical Application of Venetoclax in Chronic Lymphocytic Leukemia and Related B Cell Malignancies.

A W Roberts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.